# Dutasteride in Treating Patients With Recurrent Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapy

> **NCT00403000** · PHASE2 · COMPLETED · sponsor: **Roswell Park Cancer Institute** · enrollment: 27 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** dutasteride

## Key facts

- **NCT ID:** NCT00403000
- **Lead sponsor:** Roswell Park Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12
- **Primary completion:** 2007-03
- **Final completion:** 2013-04
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2013-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00403000

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00403000, "Dutasteride in Treating Patients With Recurrent Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapy". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00403000. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*